Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia.
Endocrinology. 2018 Feb 1;159(2):710-722. doi: 10.1210/en.2017-00739.
Placental growth factor (PGF) is member of the vascular endothelial growth factor (VEGF) family of angiogenesis regulators. VEGFA is an established regulator of ovulation and formation of the corpus luteum. To determine whether PGF also mediates aspects of ovulation and luteinization, macaques received gonadotropins to stimulate multiple follicular development. Ovarian biopsies and whole ovaries were collected before (0 hours) and up to 36 hours after human chorionic gonadotropin (hCG) administration to span the ovulatory interval. PGF and VEGFA were expressed by both granulosa cells and theca cells. In follicular fluid, PGF and VEGFA levels were lowest before hCG. PGF levels remained low until 36 hours after hCG administration, when PGF increased sevenfold to reach peak levels. Follicular fluid VEGFA increased threefold to reach peak levels at 12 hours after hCG, then dropped to intermediate levels. To explore the roles of PGF and VEGFA in ovulation, luteinization, and follicular angiogenesis in vivo, antibodies were injected into the follicular fluid of naturally developed monkey follicles; ovariectomy was performed 48 hours after hCG, with ovulation expected about 40 hours after hCG. Intrafollicular injection of control immunoglobulin G resulted in no retained oocytes, follicle rupture, and structural luteinization, including granulosa cell hypertrophy and capillary formation in the granulosa cell layer. PGF antibody injection resulted in oocyte retention, abnormal rupture, and incomplete luteinization, with limited and disorganized angiogenesis. Injection of a VEGFA antibody resulted in oocyte retention and very limited follicle rupture or structural luteinization. These studies demonstrate that PGF, in addition to VEGFA, is required for ovulation, luteinization, and follicular angiogenesis in primates.
胎盘生长因子(PGF)是血管内皮生长因子(VEGF)家族中血管生成调节剂的成员。VEGFA 是排卵和黄体形成的既定调节剂。为了确定 PGF 是否也介导排卵和黄体化的某些方面,猕猴接受促性腺激素刺激多个卵泡发育。在人绒毛膜促性腺激素(hCG)给药前(0 小时)和给药后长达 36 小时收集卵巢活检和整个卵巢,以跨越排卵间隔。PGF 和 VEGFA 均由颗粒细胞和膜细胞表达。在卵泡液中,PGF 和 VEGFA 的水平在 hCG 之前最低。PGF 水平一直保持低水平,直到 hCG 给药后 36 小时,此时 PGF 增加了七倍达到峰值。卵泡液 VEGFA 增加了三倍,在 hCG 后 12 小时达到峰值,然后降至中间水平。为了探索 PGF 和 VEGFA 在体内排卵、黄体化和卵泡血管生成中的作用,将抗体注入自然发育的猴卵泡的卵泡液中;hCG 后 48 小时进行卵巢切除术,预计 hCG 后约 40 小时排卵。在卵泡内注射对照免疫球蛋白 IgG 不会导致卵母细胞保留、卵泡破裂和结构黄体化,包括颗粒细胞肥大和颗粒细胞层中的毛细血管形成。PGF 抗体注射导致卵母细胞保留、异常破裂和不完全黄体化,血管生成有限且紊乱。VEGFA 抗体注射导致卵母细胞保留和非常有限的卵泡破裂或结构黄体化。这些研究表明,PGF 除了 VEGFA 之外,还需要在灵长类动物中排卵、黄体化和卵泡血管生成。